Search by Categories
- Insights
- Rare Disease
- Oncology
- Cell and Gene Therapy
- Medical Devices
- Consulting
- News & Analysis
-
Therapeutic Areas
Our expertise in the industry
Botanical Bounty: Cracking the Herbal Medicine Market Enigma and Growth Potential
Herbal Medicine, rooted in ancient traditions across cultures worldwide, has witnessed a remarkable evolution in the modern era. The global Herbal Medicine Market has experienced significant growth over the years, fueled by a resurgence of interest in natural remedies and a growing awareness of the potential health benefits offered by botanical extracts. From traditional herbal preparations to standardized extracts and modern formulations, the market has expanded to cater to diverse consumer needs and preferences. Herbal Medicine offers a plethora of benefits, including holistic approaches to health, reduced side effects compared…
Regeneron’s Odronextamab BLA; Novo Nordisk’s Cardior Pharmaceuticals Acquisition; Novartis’ Fabhalta CHMP Approval; Idorsia’s TRYVIO FDA Approval; AbbVie’s Landos Biopharma Acquisition
Regeneron Updates Progress on Biologics License Application for Odronextamab Regeneron Pharmaceuticals, Inc. has announced that the FDA has issued Complete Response Letters (CRLs) regarding the Biologics License Application (BLA) for odronextamab in cases of relapsed/refractory (R/R) follicular lymphoma (FL) and relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL), each occurring after two or more lines of systemic therapy. The sole concern for approval is associated with the status of enrollment in the confirmatory trials. The CRLs, one for R/R FL and one for R/R DLBCL did not highlight any concerns regarding…
Gene Therapies for Epidermolysis Bullosa Treatment: The Next Frontier in Dermatology
Epidermolysis bullosa is a genetic skin condition marked by severe skin sensitivity and the formation of blisters even from minor friction or injury. This disorder arises from genetic changes that impact the proteins crucial for upholding the skin’s structural strength. The degree of severity in epidermolysis bullosa can vary significantly, spanning from mild forms to those posing life-threatening risks, contingent upon the particular subtype. Blistering that occurs in any type of epidermolysis bullosa can lead to further problems such as infection, sepsis, and even death. Infants with severe forms of…